Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Scala

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
Scientific Reports|May 29, 2015
Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancerMichele Cioffi, Crescenzo D'Alterio, Rosalba Camerlingo, et al.
Cytokine|March 7, 2006
Soluble interleukin-2 receptor in stage I-III melanomaAlessandro Ottaiano, Enrico Leonardi, Ester Simeone, et al.
Cancer Immunology, Immunotherapy : CII|December 14, 2004
Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cellsAlessandro Ottaiano, Antonella di Palma, Maria Napolitano, et al.
Cancer Biology & Therapy|January 12, 2010
Histomorphologic parameters and CXCR4 mRNA and protein expression in sentinel node melanoma metastasis are correlated to clinical outcomeRenato Franco, Monica Cantile, Stefania Scala, et al.
Journal of Translational Medicine|November 23, 2012
Fc gamma receptor IIIa polymorphisms in advanced colorectal cancer patients correlated with response to anti-EGFR antibodies and clinical outcomeRosa Calemma, Alessandro Ottaiano, Anna Maria Trotta, et al.
Oncotarget|April 1, 2015
Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patientsMaria Napolitano, Crescenzo D'Alterio, Eleonora Cardone, et al.
Frontiers in Immunology|October 30, 2020
CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem CellsOrazio Fortunato, Dimas Carolina Belisario, Mara Compagno, et al.
Journal of Medicinal Chemistry|March 10, 2018
Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer CellsDiego Brancaccio, Donatella Diana, Salvatore Di Maro, et al.
BJU International|March 19, 2013
Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinomaMarianeve Polimeno, Maria Napolitano, Susan Costantini, et al.
Cancer Immunology Research|January 29, 2016
Prospective Evaluation of Cetuximab-Mediated Antibody-Dependent Cell Cytotoxicity in Metastatic Colorectal Cancer Patients Predicts Treatment EfficacyAnna Maria Trotta, Alessandro Ottaiano, Carmela Romano, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Scientific Reports|May 29, 2015
Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancerMichele Cioffi, Crescenzo D'Alterio, Rosalba Camerlingo, et al.
Cytokine|March 7, 2006
Soluble interleukin-2 receptor in stage I-III melanomaAlessandro Ottaiano, Enrico Leonardi, Ester Simeone, et al.
Cancer Immunology, Immunotherapy : CII|December 14, 2004
Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cellsAlessandro Ottaiano, Antonella di Palma, Maria Napolitano, et al.
Cancer Biology & Therapy|January 12, 2010
Histomorphologic parameters and CXCR4 mRNA and protein expression in sentinel node melanoma metastasis are correlated to clinical outcomeRenato Franco, Monica Cantile, Stefania Scala, et al.
Journal of Translational Medicine|November 23, 2012
Fc gamma receptor IIIa polymorphisms in advanced colorectal cancer patients correlated with response to anti-EGFR antibodies and clinical outcomeRosa Calemma, Alessandro Ottaiano, Anna Maria Trotta, et al.
Oncotarget|April 1, 2015
Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patientsMaria Napolitano, Crescenzo D'Alterio, Eleonora Cardone, et al.
Frontiers in Immunology|October 30, 2020
CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem CellsOrazio Fortunato, Dimas Carolina Belisario, Mara Compagno, et al.
Journal of Medicinal Chemistry|March 10, 2018
Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer CellsDiego Brancaccio, Donatella Diana, Salvatore Di Maro, et al.
BJU International|March 19, 2013
Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinomaMarianeve Polimeno, Maria Napolitano, Susan Costantini, et al.
Cancer Immunology Research|January 29, 2016
Prospective Evaluation of Cetuximab-Mediated Antibody-Dependent Cell Cytotoxicity in Metastatic Colorectal Cancer Patients Predicts Treatment EfficacyAnna Maria Trotta, Alessandro Ottaiano, Carmela Romano, et al.
Pageof 13